Veracyte, Inc.

Total Valuation

Veracyte, Inc. carries a market capitalization of 3.39B, placing it among publicly traded companies globally. Its enterprise value stands at 4.24B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Veracyte, Inc. currently has 79.79M shares outstanding.

Valuation Ratios

Veracyte, Inc. trades at a trailing price-to-earnings ratio of 40.71. The price-to-sales ratio is 8.29, and the price-to-book ratio stands at 3.38.

Enterprise Valuation

On an enterprise value basis, Veracyte, Inc. trades at an EV/EBITDA multiple of 32.75 and an EV/FCF ratio of 22.23. The EV/Sales ratio of 7.55 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 39.04 provides insight into valuation relative to core operating earnings.

Financial Position

Veracyte, Inc. maintains a current ratio of 9.16, meaning it holds 9.2x the short-term assets needed to cover near-term liabilities.

Financial Efficiency

Veracyte, Inc. posts a return on equity of 8.77 and a return on invested capital of 7.94.

Taxes

Over the trailing twelve months, Veracyte, Inc. has paid 1.54M in income taxes, reflecting an effective tax rate of 1.32.

Stock Price Statistics

Veracyte, Inc.'s stock has gained approximately 34.9302% over the past 52 weeks. The 50-day moving average sits at 51.03, while the 200-day moving average is 42.63.

Income Statement

Over the trailing twelve months, Veracyte, Inc. generated 561.90M in revenue and converted that into 114.48M in net income, yielding earnings per share of 1.41. EBITDA reached 129.48M, while operating income came in at 108.65M.

Balance Sheet

Veracyte, Inc. holds 485.23M in cash and equivalents against 40.11M in total debt, resulting in a net debt position of -299.52M. Total book value stands at 1.39B, with working capital of 512.04M providing operational flexibility.

Cash Flow

Veracyte, Inc. produced 178.38M in operating cash flow over the past twelve months. After subtracting -12.39M in capital expenditures, free cash flow totaled 165.99M - equivalent to 2.09 per share.

Margins

Veracyte, Inc. operates with a gross margin of 71.71, reflecting its pricing power and cost economics. The operating margin of 19.34 and net profit margin of 20.37 provide insight into operational efficiency.

Dividends & Yields

Scores

Veracyte, Inc. posts an Altman Z-Score of 30.40, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.